Thyroid function in potential organ donors. Influence on myocardial damage

Pedro Benito,Jose A. Montero,Luis Avila,Jesús Mallol,Alfonso Blanco,Magdalena Rodriguez,Francisco Alvarez,Manuel Concha

DOI: https://doi.org/10.1111/j.1399-0012.1989.tb00568.x

1989-12-01

Clinical Transplantation

Abstract:Thyroid function before and after brain death, and triiodothyronine (T3) bioavailability of the retrieved donor heart, were studied in potential organ donors to evaluate the therapeutic possibilities of using T3 to improve cardiac performance after heart transplantation. Before brain death, T3 levels were lower (0.81 ± 0.18 nmol/1) than those of controls (1.78 ± 0.27 nmol/1, p<0.01), reverse T3 (rT3) levels were significantly higher (2747.36 ± 762 pmol/1 vs 205.66 ± 59 pmol/1, p< 0.001), and TSH levels increased following TRH stimulation test. After brain death, T4 and rT3 levels decreased (p< 0.001), whereas T3 levels remained unchanged and the TSH response to TRH was abolished. Occupied T3 receptors were lower in the retrieved donor heart (3 receptors/3 μm 2 ), than in healthy myocardium (15 reccptors/3 μm 2 ). Thus, before brain death, potential organ donors seem to have a “low T3 syndrome” with increased production of rT3 for metabolic adaptation of the thyroid axis to their illness. In these cases T3 treatment is not required. On the other hand, after brain death patients become hypothyroid, reducing the tissue bioavailability of T3 (diminished occupied receptors) on the retrieved donor heart. Taking into account the importance of this hormone in myocardial function, T3 treatment seems justified in these patients after brain death in order to improve the transplanted heart performance.

surgery,transplantation